JPRN-UMIN000022139已完成未知
Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Chronic hemodialysis Patients with Coronary Artery Disease - Switching from Clopidogrel to Prasugrel in Dialysis Patients
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with contraindications to prasugrel 2. Patients who have severe liver problem 3. Weight is 50 kg or less 4. low platelet counts (less than 10*10^4) 5. Pregnant 6. Lactating 7. Patients who are taking anticoagulants 8. Patients who are planned to administer thrombolytic agents 9. Patients scheduled for PCI or coronary artery bypass graft during this study 10. Patents who are planed to change hemodialysis characteristics during this study 11. Patients who are taking ticlopidine or cilostazol 12. Patients judged as inappropriate for trial entry
研究者
相似试验
已完成
不适用
High on-Clopidogrel Platelet Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention – a pilot studyCoronary artery diseaseAtrial fibrillation, Heart attack, Stroke, Thromboembolic event, Stent thrombosisI21I25I26I48I63Pulmonary embolismChronic ischaemic heart diseaseAtrial fibrillation and flutterCerebral infarctionAcute myocardial infarctionDRKS00021212Kardiologie und Angiologie158
已完成
不适用
Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Patients with Coronary Artery DiseaseIschemic heart diseaseJPRN-UMIN000014528Chiba University Hospital53
已完成
不适用
High-on Clopidogrel Platelet Reactivity as Assessed by Thromboelastography in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.I21I25I26Chronic ischaemic heart diseaseAcute myocardial infarctionPulmonary embolismDRKS00024509Kardiologie und Angiologie172
进行中（未招募）
不适用
Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients - Plavix and PrasugrelTo investigate the feasibility, safety and cost of using the platelet assay VerifyNow-P2Y12 to guide optimal P2Y12 platelet inhibition in patients undergoing elective PCI, compared with standard treatment, at a UK tertiary referral cardiology centre.EUCTR2010-018435-18-GBPapworth Hospital NHS Foundation Trust200
已完成
不适用
Platelet response to prasugrel and clopidogrel loadinig doses in elective PCI patientsElective PCIJPRN-UMIN000017624Division of Cardiovascular Medicine, Jichi Medical University School of Medicine40